Sero-response to measles-mumps-rubella vaccine campaign in Saudi Arabia

被引:0
|
作者
Al-Mazrou, YY [1 ]
Khalil, MK [1 ]
Tumsah, S [1 ]
Al-Ghamdi, YS [1 ]
Al-Jeffri, MH [1 ]
Tischer, AB [1 ]
Mishkhas, AA [1 ]
Eissa, M [1 ]
机构
[1] Minist Hlth, Dept Prevent Med, Riyadh 11176, Saudi Arabia
关键词
measles-mumps-rubella vaccine campaign; antibody;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate the measles-mumps-rubella vaccine campaign targeting primary school children in the Kingdom of Saudi Arabia during the months of January and February 2000. Method: Pre and post measles-mumps-rubella vaccine blood samples were collected from 54 children from the first grade and 96 children from the 6th grade. Antibodies against measles, mumps and rubella were assayed using enzyme immunoassay and a backup test of plaque neutralization test. This assay was carried out at the Reference Center, Koch Institute, Berlin, Germany. Results: When the backup test results were added, 96%-98% of children had protection level against measles before the campaign. It is interesting to notice that pre-vaccination measles mean titer and positivity rate with enzyme linked immunoassay in the first grade were significantly lower than the 6th grade. One hundred percent and 96.8% were positive for rubella antibody before the campaign, in the first and 6th grades. Seventy-seven percent and 67% were positive for mumps before the campaign, in the first and 6th grade. After the measles-mumps-rubella vaccine campaign, protection rate reached 100% for the 3 antigens with a statistically significant boosting effect and increase in geometric mean of the titre. Conclusion: Measles-mumps-rubella vaccine campaign C, was effective in increasing protective levels and boosting antibodies against the 3 targeted diseases which can prevent epidemics in the primary schools.
引用
收藏
页码:680 / 683
页数:4
相关论文
共 50 条
  • [31] SYSTEMIC REACTIONS TO MEASLES-MUMPS-RUBELLA VACCINE SKIN TESTING
    PUVVADA, L
    SILVERMAN, B
    BASSETT, C
    CHIARAMONTE, LT
    PEDIATRICS, 1993, 91 (04) : 835 - 836
  • [32] BENEFITS, RISKS, AND COSTS OF IMMUNIZATION WITH MEASLES-MUMPS-RUBELLA VACCINE
    WHITE, CC
    KOPLAN, JP
    ORENSTEIN, WA
    MEDICAL DECISION MAKING, 1983, 3 (03) : 353 - 353
  • [33] Parotitis and Orchitis Cases due to Measles-Mumps-Rubella Vaccine
    Sultanova, Fidan
    Ozger, Hasan Selcuk
    Ozer, Fatma
    Yildiz, Yesim
    Senol, Esin
    KLIMIK JOURNAL, 2022, 35 (01) : 46 - 48
  • [34] Persistence of Rubella Antibodies after 2 Doses of Measles-Mumps-Rubella Vaccine
    LeBaron, Charles W.
    Forghani, Bagher
    Matter, Lukas
    Reef, Susan E.
    Beck, Carol
    Bi, Daoling
    Cossen, Cynthia
    Sullivan, Bradley J.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (06): : 888 - 899
  • [35] Has the measles-mumps-rubella vaccine been fully exonerated?
    Katz, Samuel L.
    PEDIATRICS, 2006, 118 (04) : 1744 - 1745
  • [36] IMMUNE SERUM GLOBULIN (IG) EFFECT ON RESPONSE TO MEASLES-MUMPS-RUBELLA (MMR) VACCINE
    FRANK, JA
    ORENSTEIN, WA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (02) : 216 - 216
  • [37] Dextran-specific IgG response in hypersensitivity reactions to measles-mumps-rubella vaccine
    Zanoni, Giovanna
    Puccetti, Antonio
    Dolcino, Marzia
    Simone, Rita
    Peretti, Andrea
    Ferro, Antonio
    Tridente, Giuseppe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (06) : 1233 - 1235
  • [38] Age for routine administration of the second dose of measles-mumps-rubella vaccine
    Halsey, NA
    Abramson, JS
    Chesney, PJ
    Fisher, MC
    Gerber, MA
    Gromisch, DS
    Kohl, S
    Marcy, SM
    Murray, DL
    Overturf, GD
    Whitley, RJ
    Yogev, R
    Peter, G
    Hall, CB
    Schwartz, B
    Breiman, R
    Hardegree, MC
    Jacobs, RF
    MacDonald, NE
    Orenstein, WA
    Rabinovich, NR
    PEDIATRICS, 1998, 101 (01) : 129 - 133
  • [39] Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants
    D'Angio, Carl T.
    Boohene, Paulina A.
    Mowrer, Anne
    Audet, Susette
    Menegus, Marilyn A.
    Schmid, D. Scott
    Beeler, Judy A.
    PEDIATRICS, 2007, 119 (03) : E574 - E579
  • [40] Safety of measles-mumps-rubella vaccine (MMR) in patients allergic to eggs
    Cerecedo Carballo, I.
    Dieguez Pastor, M. C.
    Bartolome Zavala, B.
    Sanchez Cano, M.
    de la Hoz Caballer, B.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2007, 35 (03) : 105 - 109